Steven K. Burke

Insider Reports History

Entity
Individual
Location
82 Willis Road, Sudbury, MA
Signature
/s/ Carolyn Rucci, attorney-in-fact for Steven K. Burke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven K. Burke:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Medical Officer Common Stock 696K $1.1M $1.58 Feb 29, 2024 Direct
Akebia Therapeutics, Inc. SVP, Chief Medical Officer Stock Option (Right to buy) 303K Jan 31, 2024 Direct

Insider Reports Filed by Steven K. Burke

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKBA Akebia Therapeutics, Inc. Feb 29, 2024 1 -$11.3K 4 Mar 1, 2024 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Feb 27, 2024 1 -$12.7K 4 Feb 29, 2024 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2024 3 -$40.8K 4 Feb 2, 2024 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Aug 25, 2023 1 -$31.1K 4 May 9, 2024 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. May 16, 2023 1 -$67.9K 4 May 18, 2023 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Mar 1, 2023 3 -$12.4K 4 Mar 3, 2023 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Feb 27, 2023 1 -$6.13K 4 Mar 1, 2023 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Aug 31, 2022 1 -$416 4 Sep 1, 2022 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. May 12, 2022 2 $0 4 May 16, 2022 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Feb 28, 2022 5 -$32.6K 4 Mar 2, 2022 SVP, Chief Medical Officer
AKBA Akebia Therapeutics, Inc. Aug 31, 2021 1 -$2.95K 4 Sep 2, 2021 SVP, Chief Medical Officer